BioSpace News Archive

Sunesis Pharmaceuticals, Inc. announced a poster presentation at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held October 26-30, 2019 in Boston, Massachusetts..

Data from four of the Company’s pipeline programs will be presented in poster sessions at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held October 26-30, 2019 in Boston, MA.

Third Quarter 2019 earnings conference call on Wednesday, October 23rd at 1:00 p.m. Eastern Time.

Tandem Diabetes Care, Inc. announced publication by the New England Journal of Medicine of results from the landmark Protocol 3 study of the National Institutes of Health -funded International Diabetes Closed Loop trial using the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology.

Agitation is a neuropsychiatric symptom of dementia and can indicate that a person with ADRD has an acute medical condition, is in distress or has unmet needs.

Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT

MassBioHub is a unique and flexible space to accommodate groups of 2-200 for members’ business needs, from informal staff huddles to full-scale conferences and corporate events

The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Shionogi & Co., Ltd. announced that the U.S. Food and Drug Administration’s Antimicrobial Drugs Advisory Committee voted to recommend approval of the investigational antibiotic cefiderocol for the treatment of complicated urinary tract infections, including pyelonephritis, in patients with limited or no alternative treatment options.